Zevra Therapeutics, Inc. (ZVRA)

Market price: $10.13

2 valuation methods

• P / B: $4.91 to $15.72 (midpoint $8.08)
• EV / Revenue: $15.15 to $26.04 (midpoint $20.59)

Pre-profit company — earnings-based methods not meaningful.

Limited data — fewer than three valuation methods could be formed for this company; showing every method we can stand behind.